If you have a known heart rhythm condition, experience unexplained fainting, or take medications that affect heart rhythm, its best to avoid this supplement or speak with a healthcare professional first
Glucagon-like peptide 1 (GLP-1) receptor agonists' use during pregnancy: Safety data from regulatory clinical trials
Peptide chains denature when ice crystals form, and the damage is irreversible
27 In vitro activation of the GLP-1R by exendin-4 enhanced osteogenic differentiation while inhibiting adipogenic differentiation of BMSCs
For example, GLP-1 analogs have been shown to diminish the desire for sweet, salty, fatty, and savory foods, further supporting their role in shifting food preferences toward less palatable options (Kadouh et al., 2020)
The competitive landscape for obesity medications continues intensifying